Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vanda Pharmaceuticals Inc. Director's Dealing 2014

Dec 24, 2014

33390_dirs_2014-12-24_8a60d2cd-8e8b-4237-bef6-803753943c72.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2014-12-23

Reporting Person: Flynn James E (10% Owner, Possible Member of 10% Group)
Reporting Person: Deerfield Mgmt L.P. (10% Owner, Possible Member of 10% Group)
Reporting Person: DEERFIELD MANAGEMENT CO (10% Owner, Possible Member of 10% Group)
Reporting Person: Deerfield International Master Fund, L.P. (10% Owner, Possible Member of 10% Group)
Reporting Person: DEERFIELD PARTNERS, LP (10% Owner, Possible Member of 10% Group)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-23 Common Stock P 11100 $14.23 Acquired 1285881 Indirect
2014-12-23 Common Stock P 13900 $14.23 Acquired 1598601 Indirect
2014-12-23 Common Stock P 13320 $14.48 Acquired 1299201 Indirect
2014-12-23 Common Stock P 16680 $14.48 Acquired 1615281 Indirect
2014-12-23 Common Stock P 11100 $14.50 Acquired 1310301 Indirect
2014-12-23 Common Stock P 13900 $14.50 Acquired 1629181 Indirect
2014-12-23 Common Stock P 8880 $14.33 Acquired 1319181 Indirect
2014-12-23 Common Stock P 11120 $14.33 Acquired 1640301 Indirect
2014-12-23 Common Stock P 11100 $14.30 Acquired 1330281 Indirect
2014-12-23 Common Stock P 13900 $14.30 Acquired 1654201 Indirect
2014-12-23 Common Stock P 16434 $14.48 Acquired 1346715 Indirect
2014-12-23 Common Stock P 20580 $14.48 Acquired 1674781 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 610588 Indirect
Common Stock 507703 Indirect

Footnotes

F1: This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt, L.P. is the general partner of Deerfield Special Situations Fund, L.P., Deerfield Special Situations International Master Fund, L.P., Deerfield Partners, L.P. and Deerfield International Master Fund, L.P. (collectively, the "Funds"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.

F2: In accordance with Instruction 5 (b)(iv) to Form 3, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.